High-high intermediate risk endometrial adenocarcinoma: A subset of early stage endometrial cancer patients who benefit from adjuvant therapy

被引:0
|
作者
Roane, B. M. [1 ]
Kamal, M. Z. [1 ]
Rushton, T. [1 ]
Barrington, D. A. [1 ]
McGwin, G. [1 ]
Arend, R. C. [1 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
10.1016/j.ygyno.2019.04.476
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2249
引用
收藏
页码:205 / 205
页数:1
相关论文
共 50 条
  • [41] THE ROLE OF ADJUVANT CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER
    Colombo, Nicoletta
    Parma, Gabriella
    Lapresa, Maria Teresa
    Mancari, Rosanna
    Peiretti, Michele
    Sanguineti, Fabio
    Festi, Anna
    ANNALS OF ONCOLOGY, 2009, 20 : 9 - 9
  • [42] Comparison of Outcomes in Patients with Early-stage Mucinous Endometrial Cancer and Those with Endometrioid Endometrial Cancer, With and Without Adjuvant Therapy
    Owusu-Darko, Sharon
    Rauh-Hain, J. Alejandro
    Horowitz, Neil S.
    Goodman, Annekathryn
    Schorge, John O.
    del Carmen, Marcela G.
    JOURNAL OF REPRODUCTIVE MEDICINE, 2014, 59 (11-12) : 527 - 533
  • [43] High intermediate risk endometrial cancer. What is it?
    Eifel, Patricia J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (07) : 1084 - 1085
  • [44] Brachytherapy versus external beam radiation therapy in high intermediate risk endometrial cancer patients
    Delic, L.
    Cass, I.
    Li, A.
    Leuchter, R.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 383 - 384
  • [45] Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer
    Randall, Marcus E.
    Filiaci, Virginia
    McMeekin, D. Scott
    von Gruenigen, Vivian
    Huang, Helen
    Yashar, Catheryn M.
    Mannel, Robert S.
    Kim, Jae-Weon
    Salani, Ritu
    DiSilvestro, Paul A.
    Burke, James J.
    Rutherford, Thomas
    Spirtos, Nick M.
    Terada, Keith
    Anderson, Penny R.
    Brewster, Wendy R.
    Small, William
    Aghajanian, Carol A.
    Miller, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (21) : 1810 - +
  • [46] Characteristics and prognosis of patients with early-stage endometrial cancer who refuse adjuvant radiotherapy
    Koskas, Martin
    Huchon, Cyrille
    Amant, Frederic
    GYNECOLOGIC ONCOLOGY, 2016, 141 (03) : 428 - 433
  • [47] Adjuvant high dose rate vaginal cuff brachytherapy for early stage endometrial cancer
    Tannehill, SP
    Petereit, DG
    Schink, JC
    Grosen, EA
    Hartenbach, EM
    Thomadsen, BR
    Buchler, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 296 - 296
  • [48] Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion
    Son, Ji
    Chambers, Laura M.
    Carr, Caitlin
    Michener, Chad M.
    Yao, Meng
    Beavis, Anna
    Yen, Ting-Tai
    Stone, Rebecca L.
    Wethington, Stephanie L.
    Fader, Amanda N.
    Burkett, Wesley C.
    Richardson, Debra L.
    Staley, Allison S.
    Ahn, Susie
    Gehrig, Paola A.
    Torres, Diogo
    Dowdy, Sean C.
    Sullivan, Mackenzie W.
    Modesitt, Susan C.
    Watson, Catherine
    Veade, Ashley
    Ehrisman, Jessie
    Havrilesky, Laura
    Secord, Angeles Alvarez
    Loreen, Amy
    Griffin, Kaitlyn
    Jackson, Amanda
    Viswanathan, Akila
    Ricci, Stephanie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (11) : 1738 - 1747
  • [49] Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer
    Zusterzeel, P. L. M.
    Bekkers, R. L. M.
    Hendriks, J. C. M.
    Neesham, D. N.
    Rome, R. M.
    Quinn, M. A.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (02) : 240 - 246
  • [50] Adjuvant CAP in endometrial cancer. Adjuvant chemotherapy with cisplatin, adriamycin, and cyclophosphamide following in patients with high-risk endometrial cancer
    Tomioka, Y
    Kumagai, S
    Fujiyoshi, K
    Hirai, N
    Sugiyama, T
    Nishida, T
    Kamura, T
    7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY, 1999, : 157 - 161